Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

News · November 20, 2018

SNO 2018: The Dopamine Receptor D2 Antagonist ONC201 Appears to Exhibit Clinical Activity in Some Patients With H3 K27M-Mutant Glioma

Updated clinical data continue to support this novel agent.

PracticeUpdate Editorial Team

 

Further Reading